10. When Patents Are Not Enough: Data Exclusivity for Follow-On Biologics, by John E. Calfee
9. FDA Preemption and Patient Welfare in Wyeth v. Levine, by John E. Calfee
8. Quantity and Quality: An Rx for Efficient Drug Purchasing, by Roger Bate and Karen Porter
7. Entitlements: Not Just a Health Care Problem, by Andrew G. Biggs

6. As Arizona Goes, So Goes the Nation: How Medicaid Ruins the States' Fiscal Health, by Michael S. Greve and Philip Wallach
5. Have Health Reformers Forgotten Medicare? by Joseph Antos
4. Rolling Back Malaria: Rhetoric and Reality in the Fight against a Deadly Killer, by Roger Bate
3. Medicare's Bad News: Is Anyone Listening? by Joseph Antos
2. More Drugs for More Developing World Diseases, by Roger Bate and Karen Porter
1. Paging Dr. Ricardo: A Dose of Economics for Healthier Pharmaceutical Production, by Roger Bate

 

 

14. The Rise, Fall, Rise, and Imminent Fall of DDT, by Roger Bate

13. First, Do No Harm: The Toll of Unhealthy Health Care Practices, by Lorraine Mooney and Roger Bate

12. Reform without Reason: What's Wrong with the FDA Amendments Act of 2007, by John E. Calfee

11. The Bush Administration's Health Insurance Tax Reform Proposal: A Second Look, by Bryan E. Dowd
10. The SCHIP Open: Hidden Incentives for States to Spend Federal Funds, by Robert B. Helms
9. Drug Pricing and Its Discontents: At Home and Abroad, by Roger Bate and Kathryn Boateng
8. Bad Medicine in the Market, by Roger Bate and Kathryn Boateng
7. Unchecked Idealism: WHO's Epidemic, by Roger Bate
6. Facing Reality on Follow-On Biologics, by John E. Calfee
5. Thailand and the Drug Patent Wars, by Roger Bate
4. On the Trail of a Cure: Reality and Rhetoric on Treating Malaria, by Roger Bate
3. India and the Drug Patent Wars, by Roger Bate
2. The Medicaid Commission Report: A Dissent, by Robert B. Helms
1. Is Massachusetts a Model at Last? by Mark V. Pauly

 

 

10. Medicinal Malpractice, by Roger Bate and Kathryn Boateng
9. South Africa’s Grown-Up Response to the AIDS Crisis, by Roger Bate
8. Government-Controlled Pharmaceutical Research and Development, by Richard Tren and Roger Bate
7. Crisis du Jour or the Real Thing? by Joseph Antos
6. Bad Medicine, by Roger Bate
5. Playing Catch-up, by John E. Calfee

4. The WTO and Access to Essential Medicines: Recent Agreements, New Assignments, by Roger Bate and Richard Tren

3. WHO's AIDS Target, by Roger Bate
2. Cutting through Confusion in Part D, by Joseph Antos
1. Brazil's AIDS Program, by Richard Tren and Roger Bate

November-December - Is H5N1 the One?, by Laura M. Kelley 
September-October - The Vioxx Fallout, by John E. Calfee
July-August - Inflated Claims about Drug Prices, by Joseph Antos and Thomas F. Wildsmith
May-June - Slippery AIDS Statistics, by Roger Bate
March-April - Health Policy on a Budget, by Joseph Antos
January-February - Tax Reform and Health Insurance, by Robert B. Helms

November-December - Putting Markets to Work in Vaccine Manufacturing, by John E. Calfee and Scott Gottlieb
September-October - Kerry, Bush, and the Uninsured, by Joseph Antos
July-August - The Real Obstacles to Sound Treatment of AIDS in Poor Countries, by Roger Bate and Richard Tren
May-June - The Official Future of Medicare, by Robert B. Helms
March-April - Don't Ask, Don't Tell, by Joseph Antos
January-February - Of Sausage-Making and Medicare, by Joseph Antos and John E. Calfee

2003

November - The Grim Economics of Pharmaceutical Importation, by John E. Calfee
September-October - How to Overcome Four Key Obstacles to a Medicare Drug Benefit, by Joseph Antos